ICD-10-CM Billable Code

C44.719

Basal cell carcinoma of skin of left lower limb, including hip

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) is the most common type of skin cancer. Specifically, when it occurs on the skin of the left lower limb, including the hip, it presents unique considerations due to the location. While BCC typically grows slowly and rarely spreads to other parts of the body, its presence requires attention to ensure effective treatment and management. Recognizing the risk factors, symptoms, and treatment options is essential for those diagnosed with this condition.

Causes & Symptoms

Clinical Causes: The primary cause of basal cell carcinoma is prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Other contributing factors include: - Fair skin, which is more susceptible to sun damage - History of sunburns, especially during childhood - Chronic skin injuries or inflammation - Exposure to certain chemicals or radiation - Genetic predispositions, such as basal cell nevus syndrome - Weakened immune system, which impairs the body's ability to identify and destroy abnormal cells - Age, as risk increases with advancing years - Exposure to arsenic and other carcinogens

Key Symptoms: Noticing certain signs can help identify basal cell carcinoma early. Symptoms on the skin of the left lower limb, including the hip, may include: - Persistent, non-healing open sore or ulcer - Slightly raised, shiny, and translucent bump or nodule - Pink, red, or pigmented growth that may bleed or crust - Scar-like area that appears shiny or waxy - New or changing growths or spots on the skin - Sensation of tenderness or mild pain in the affected area - Lesions that may be ulcerated or crusted, - Lesions that are asymptomatic but may become sore or bleed - The growth typically develops slowly and may be overlooked initially

Diagnostic & Treatment

Diagnosis Path: Diagnosing basal cell carcinoma involves a combination of clinical examination and diagnostic tests: - Physical inspection of the skin for suspicious lesions - Dermatoscopy, a specialized skin examination tool, to evaluate the lesion's features - Skin biopsy, where a sample of the abnormal tissue is removed and examined microscopically to confirm the diagnosis - Further imaging studies may be warranted if there's concern about the lesion's depth or extent, such as ultrasound or MRI - Histopathological analysis is essential for confirming BCC and ruling out other types of skin cancer

Treatment Protocols: Effective management of basal cell carcinoma typically involves removal of the cancerous tissue. Common treatment options include: - Surgical excision, where the lesion is cut out along with a margin of healthy tissue - Mohs micrographic surgery, a precise technique to remove the cancer layer by layer while conserving healthy tissue - Curettage and electrodessication, a procedure involving scraping the lesion and cauterizing the area - Topical medications, such as imiquimod or 5-fluorouracil, especially for superficial BCCs - Radiation therapy, used in cases where surgery is not feasible - Follow-up monitoring, as BCC has a propensity to recur locally - Prevention strategies, including protecting the skin from excessive sun exposure and avoiding tanning beds - Lifestyle modifications to reduce risk factors, such as wearing protective clothing and sunscreen Always consult with a healthcare professional to determine the most appropriate treatment plan based on individual circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.719 a billable ICD-10 code?
Yes, C44.719 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.719?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of left lower limb, including hip and any associated comorbidities for accurate reporting.

Cite this Clinical Reference